| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $770.5M | +25.6% |
| R&D Expense | $73.4M | -1.5% |
| SG&A Expense | $217.5M | -2.2% |
| Operating Income | $123.2M | +511.7% |
| Pre-tax Income | $66.6M | +31.6% |
| Income Tax | -$158.6M | — |
| Net Income | $169.7M | +503.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $66.9M | +15.5% |
| Accounts Receivable | $511K | -2.9% |
| Current Assets | $662.2M | -14.0% |
| Total Assets | $1.19B | +14.3% |
| Current Liabilities | $643.1M | +16.5% |
| Total Liabilities | $957.0M | +41.6% |
| Stockholders' Equity | $198.4M | -15.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $295.7M | +31.4% |
| Capital Expenditures | $12.0M | -53.0% |
| Investing Cash Flow | $113.8M | +833.7% |
| Financing Cash Flow | -$401.5M | -85.9% |
| Free Cash Flow | $283.7M | +42.2% |